These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 30146729

  • 21. The factors that affect the prediction of lymph node metastasis in prostate cancer.
    Turk H, Ün S, Koca O, Cinkaya A, Kodaz H, Zorlu F.
    J Cancer Res Ther; 2018; 14(5):1094-1098. PubMed ID: 30197355
    [Abstract] [Full Text] [Related]

  • 22. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M, Schiavina R, Lanciotti M, Masieri L, Serni S, Vagnoni V, Abdollah F, Carini M, Martorana G, Montorsi F.
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [Abstract] [Full Text] [Related]

  • 23. Racial disparities in mortality for patients with prostate cancer after radical prostatectomy.
    Wen W, Luckenbaugh AN, Bayley CE, Penson DF, Shu XO.
    Cancer; 2021 May 01; 127(9):1517-1528. PubMed ID: 32895938
    [Abstract] [Full Text] [Related]

  • 24. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era.
    Dorin RP, Lieskovsky G, Fairey AS, Cai J, Daneshmand S.
    Urol Oncol; 2013 Nov 01; 31(8):1441-7. PubMed ID: 22516714
    [Abstract] [Full Text] [Related]

  • 25. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
    Tafuri A, Rizzetto R, Amigoni N, Sebben M, Shakir A, Gozzo A, Odorizzi K, Gallina S, Bianchi A, Ornaghi P, Brunelli M, Migliorini F, Cerruto MA, Artibani W, Siracusano S, Antonelli A, Porcaro AB.
    Urol Int; 2021 Nov 01; 105(5-6):362-369. PubMed ID: 33059351
    [Abstract] [Full Text] [Related]

  • 26. Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy?
    Lam JS, Desai M, Mansukhani MM, Benson MC, Goluboff ET.
    J Urol; 2003 Dec 01; 170(6 Pt 1):2288-91. PubMed ID: 14634398
    [Abstract] [Full Text] [Related]

  • 27. Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer.
    Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI.
    J Urol; 2021 Jul 01; 206(1):69-79. PubMed ID: 33683934
    [Abstract] [Full Text] [Related]

  • 28. Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?
    Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y.
    Int J Urol; 2013 Nov 01; 20(11):1092-6. PubMed ID: 23387553
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.
    Briganti A, Karnes JR, Da Pozzo LF, Cozzarini C, Gallina A, Suardi N, Bianchi M, Freschi M, Doglioni C, Fazio F, Rigatti P, Montorsi F, Blute ML.
    Eur Urol; 2009 Feb 01; 55(2):261-70. PubMed ID: 18838212
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T, Budäus L, Walz J, Zorn KC, Schlomm T, Chun F, Ahyai S, Fisch M, Sauter G, Huland H, Graefen M, Haese A.
    BJU Int; 2011 Jun 01; 107(11):1755-61. PubMed ID: 20942833
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
    Abdollah F, Gandaglia G, Suardi N, Capitanio U, Salonia A, Nini A, Moschini M, Sun M, Karakiewicz PI, Shariat SF, Montorsi F, Briganti A.
    Eur Urol; 2015 Feb 01; 67(2):212-9. PubMed ID: 24882672
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.
    BJU Int; 2013 May 01; 111(5):723-30. PubMed ID: 22487441
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
    Cross CK, Shultz D, Malkowicz SB, Huang WC, Whittington R, Tomaszewski JE, Renshaw AA, Richie JP, D'Amico AV.
    J Clin Oncol; 2002 Jun 15; 20(12):2863-8. PubMed ID: 12065563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.